OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
December 17, 2021
Bionique Testing Laboratories has been acquired by Asahi Kasei Medical and will join the company’s biosafety testing services unit.
December 06, 2021
Fully automated enzyme analysis can ease a persistent bottleneck in biocatalyst development for bio/pharmaceutical applications.
December 03, 2021
The companies will focus on the rapid development of polymerase chain reaction assays for emerging pathogens and potential health threats, including biological threats.
December 02, 2021
Timing is everything, and it might be ideal for acceleration of real-time monitoring solutions.
Defining expectations, such as GMPs, is paramount for sourcing the right biopharmaceutical raw materials.
Confounding signals pose challenges to analytical methods necessary for managing residual impurity removal in biotherapeutic manufacturing.
December 01, 2021
Glycosylation monitoring has been heavily dependent on manual processes, but the automation of sample preparation streamlines the overall workflow.
November 10, 2021
Part 2—Industry experts from MilliporeSigma, Lonza, Astrea Bioseparations, and Sartorius provide insight and examples about solving critical challenges in both analytics and process development for emerging therapies.
November 08, 2021
Part 1—Industry experts from MilliporeSigma, Lonza, Astrea Bioseparations, and Sartorius discuss key issues affecting the development of emerging biotherapies.
November 04, 2021
Gentronix has expanded it lab facilities and increased capacity for genetic, ocular, and skin toxicology testing.